Dr. Jay Bhattacharya

I mean, it's not like international collaboration science is normal. The way the NIH paid for these things was by something called sub awards. So an American university, some university in the United States, researcher says, I'm going to work with somebody in France. We give money to the American university. Then the university then gives the money to the lab in France or something like that.

I mean, it's not like international collaboration science is normal. The way the NIH paid for these things was by something called sub awards. So an American university, some university in the United States, researcher says, I'm going to work with somebody in France. We give money to the American university. Then the university then gives the money to the lab in France or something like that.

Anywhere, right? Doesn't matter. What I found out is that the NIH, which gives money to the US university, can't track really effectively or audit the money that's spent in that foreign lab. So the most crucial example of this is Wuhan. We can't get them to give us their lab notebooks for their experiments. We sent them money.

Anywhere, right? Doesn't matter. What I found out is that the NIH, which gives money to the US university, can't track really effectively or audit the money that's spent in that foreign lab. So the most crucial example of this is Wuhan. We can't get them to give us their lab notebooks for their experiments. We sent them money.

Anywhere, right? Doesn't matter. What I found out is that the NIH, which gives money to the US university, can't track really effectively or audit the money that's spent in that foreign lab. So the most crucial example of this is Wuhan. We can't get them to give us their lab notebooks for their experiments. We sent them money.

So I put in a system that requires the same level of auditing power and scrutiny over the foreign labs that we give money to as we have of our American labs. It's a system, it's a little bit of a transition to get there, but it's not that disruptive. We're still allowing foreign collaborations to happen. It's just that now the NIH is going to be able to audit what's happening over there.

So I put in a system that requires the same level of auditing power and scrutiny over the foreign labs that we give money to as we have of our American labs. It's a system, it's a little bit of a transition to get there, but it's not that disruptive. We're still allowing foreign collaborations to happen. It's just that now the NIH is going to be able to audit what's happening over there.

So I put in a system that requires the same level of auditing power and scrutiny over the foreign labs that we give money to as we have of our American labs. It's a system, it's a little bit of a transition to get there, but it's not that disruptive. We're still allowing foreign collaborations to happen. It's just that now the NIH is going to be able to audit what's happening over there.

The media reported as if I were banning all foreign collaborations. What we're doing is we're being able to audit foreign what's happening with American money in foreign institutions. I just, it's mind blowing to me, Vince, like how distorting a reporting can be, something that's really good and allow, in fact, will allow foreign collaborators to happen in a way that's like,

The media reported as if I were banning all foreign collaborations. What we're doing is we're being able to audit foreign what's happening with American money in foreign institutions. I just, it's mind blowing to me, Vince, like how distorting a reporting can be, something that's really good and allow, in fact, will allow foreign collaborators to happen in a way that's like,

The media reported as if I were banning all foreign collaborations. What we're doing is we're being able to audit foreign what's happening with American money in foreign institutions. I just, it's mind blowing to me, Vince, like how distorting a reporting can be, something that's really good and allow, in fact, will allow foreign collaborators to happen in a way that's like,

that the American people can be proud of instead is reported as, oh, we're some anti-science group that wants to kill all scientific collaboration. It's so far from the truth, it's remarkable. And yet the media reported it happily without even really asking me what was going on.

that the American people can be proud of instead is reported as, oh, we're some anti-science group that wants to kill all scientific collaboration. It's so far from the truth, it's remarkable. And yet the media reported it happily without even really asking me what was going on.

that the American people can be proud of instead is reported as, oh, we're some anti-science group that wants to kill all scientific collaboration. It's so far from the truth, it's remarkable. And yet the media reported it happily without even really asking me what was going on.

Thank you, Vincent. So it was a pleasure to talk.

Thank you, Vincent. So it was a pleasure to talk.

Thank you, Vincent. So it was a pleasure to talk.

What we're going to do is make sure that those prices become much closer to equal, like a competitive market you'd expect. You may think of it as somehow it's going after drug companies. Actually, it's helping drug companies.

What we're going to do is make sure that those prices become much closer to equal, like a competitive market you'd expect. You may think of it as somehow it's going after drug companies. Actually, it's helping drug companies.

What we're going to do is make sure that those prices become much closer to equal, like a competitive market you'd expect. You may think of it as somehow it's going after drug companies. Actually, it's helping drug companies.